| References |
|
|
Bose T and
Gerton JL
(2010)
Cohesinopathies, gene expression, and chromatin organization.
Journal of Cell Biology
189:
201–210.
|
|
|
van der Burg M,
Ijspeert H,
Verkaik NS et al.
(2009)
A DNA-PKcs mutation in a radiosensitive T-B-SCID patient inhibits Artemis activation and nonhomologous end-joining.
Journal of Clinical Investigation
119:
91–98.
|
|
|
Caldecott KW
(2008)
Single-strand break repair and genetic disease.
Nature Reviews. Genetics
9:
619–631.
|
|
|
Chu WK and
Hickson ID
(2009)
RecQ helicases: multifunctional genome caretakers.
Nature Reviews. Cancer
9:
644–654.
|
|
|
Digweed M and
Sperling K
(2004)
Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks.
DNA Repair (Amsterdam)
3:
1207–1217.
|
|
|
Fousteri M and
Mullenders LH
(2008)
Transcription-coupled nucleotide excision repair in mammalian cells: molecular mechanisms and biological effects.
Cell Research
18:
73–84.
|
|
|
Fousteri M,
Vermeulen W,
van Zeeland AA and
Mullenders LH
(2006)
Cockayne syndrome A and B proteins differentially regulate recruitment of chromatin remodeling and repair factors to stalled RNA polymerase II in vivo.
Molecular Cell
23:
471–482.
|
|
|
Gudmundsdottir K and
Ashworth A
(2006)
The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability.
Oncogene
25:
5864–5874.
|
|
|
Hashimoto S and
Egly JM
(2009)
Trichothiodystrophy view from the molecular basis of DNA repair/transcription factor TFIIH.
Human Molecular Genetics
18:
R224–230.
|
|
|
Jiricny J
(2006)
The multifaceted mismatch-repair system.
Nature Reviews. Molecular Cell Biology
7:
335–346.
|
|
|
Kraemer KH,
Lee MM and
Scotto J
(1987)
Xeroderma pigmentosum. Cutaneous, ocular and neurologic abnormalities in 830 published cases.
Archives of Dermatology
123:
241–250.
|
|
|
Lavin MF
(2008)
Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer.
Nature Reviews. Molecular Cell Biology
9:
759–769.
|
|
|
Lehmann AR
(2001)
The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases.
Genes & Development
15:
15–23.
|
|
|
Lieber MR
(2010)
The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway.
Annual Review of Biochemistry
79:
181–211.
|
|
|
Ma Y,
Pannicke U,
Schwarz K and
Lieber MR
(2002)
Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination.
Cell
108:
781–794.
|
|
|
Masutani C,
Kusumoto R,
Iwai S and
Hanaoka F
(2000)
Accurate translesion synthesis by human DNA polymerase .
EMBO Journal
19:
3100–3109.
|
|
|
McCulloch SD,
Kokoska RJ,
Masutani C et al.
(2004)
Preferential cis-syn thymine dimer bypass by DNA polymerase occurs with biased fidelity.
Nature
428:
97–100.
|
|
|
Meindl A,
Hellebrand H,
Wiek C et al.
(2010)
Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.
Nature Genetics
42:
410–414.
|
|
|
Moldovan GL and
D'Andrea AD
(2009)
How the fanconi anemia pathway guards the genome.
Annual Review of Genetics
43:
223–249.
|
|
|
Moshous D,
Callebaut I,
de Chasseval R et al.
(2001)
Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency.
Cell
105:
177–186.
|
|
|
Nance MA and
Berry SA
(1992)
Cockayne Syndrome: Review of 140 cases.
American Journal of Medical Genetics
42:
68–84.
|
|
|
Nouspikel T
(2009)
DNA repair in mammalian cells: Nucleotide excision repair: variations on versatility.
Cellular and Molecular Life Sciences
66:
994–1009.
|
|
|
O'Driscoll M
(2009)
Mouse models for ATR deficiency.
DNA Repair (Amsterdam)
8:
1333–1337.
|
|
|
O'Driscoll M,
Cerosaletti KM,
Girard P-M et al.
(2001)
DNA Ligase IV mutations identified in patients exhibiting development delay and immunodeficiency.
Molecular Cell
8:
1175–1185.
|
|
|
O'Driscoll M,
Ruiz-Perez VL,
Woods CG,
Jeggo PA and
Goodship JA
(2003)
A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome.
Nature Genetics
33:
497–501.
|
|
|
Rass U,
Ahel I and
West SC
(2007)
Defective DNA repair and neurodegenerative disease.
Cell
130:
991–1004.
|
|
|
Stefanini M,
Botta E,
Lanzafame M and
Orioli D
(2010)
Trichothiodystrophy: from basic mechanisms to clinical implications.
DNA Repair (Amsterdam)
9:
2–10.
|
|
|
Stewart GS,
Maser RS,
Stankovic T et al.
(1999)
The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder.
Cell
99:
577–587.
|
|
|
Stracker TH,
Theunissen JW,
Morales M and
Petrini JH
(2004)
The Mre11 complex and the metabolism of chromosome breaks: the importance of communicating and holding things together.
DNA Repair (Amsterdam)
3:
845–854.
|
|
|
Taylor AM,
Groom A and
Byrd PJ
(2004)
Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis.
DNA Repair (Amsterdam)
3:
1219–1225.
|
|
|
Vaz F,
Hanenberg H,
Schuster B et al.
(2010)
Mutation of the RAD51C gene in a Fanconi anemia-like disorder.
Nature Genetics
42:
406–409.
|
|
|
Wu L and
Hickson ID
(2003)
The Bloom's syndrome helicase suppresses crossing over during homologous recombination.
Nature
426:
870–874.
|
|
|
Zlatanou A and
Stewart GS
(2010)
A PIAS-ed view of DNA double strand break repair focuses on SUMO.
DNA Repair (Amsterdam)
9:
588–592.
|
| Further Reading |
|
|
Fernandez-Capetillo O
(2010)
Intrauterine programming of ageing.
EMBO Report
11:
32–36.
|
|
|
book
Friedberg EC,
Walker GC,
Siede W et al.
(2005)
DNA Repair and Mutagenesis, 2nd edn.
Washington DC: ASM Press.
|
|
|
Hoeijmakers JH
(2009)
DNA damage, aging, and cancer.
New England Journal of Medicine
361:
1475–1485.
|
|
|
book
Ochs HD,
Smith CIE and
Puck JM (eds)
(2006)
Primary Immunodeficiency Diseases: A Molecular and Genetic Approach, 2nd edn.
Oxford: Oxford University Press.
|
|
|
O'Driscoll M and
Jeggo PA
(2006)
The role of double-strand break repair – insights from human genetics.
Nature Reviews. Genetics
7:
45–54.
|
| Web Links |
|
| ePath Ataxia, oculomotor apraxia type 1 MIM 208920
|
|
| ePath Ataxia-telangiectasia like disorder MIM 604391
|
|
| ePath Ataxia-telangiectasia MIM 208900
|
|
| ePath Bloom Syndrome MIM 210900
|
|
| ePath Cockayne syndrome Type A MIM 216400
|
|
| ePath Cockayne syndrome Type B; MIM 133540
|
|
| ePath Cornelia de Lange syndrome MIM 122470
|
|
| ePath Fanconi Anemia MIM 227650
|
|
| ePath Nijmegen Breakage Syndrome MIM 251260
|
|
| ePath Roberts syndrome MIM 268300
|
|
| ePath Rothmund-Thomson Syndrome MIM 268400
|
|
| ePath Seckel syndrome MIM 210600
|
|
| ePath Spinocerebellar ataxia with axonal neuropathy; SCAN1 MIM 607250
|
|
| ePath Werner Syndrome MIM 277700
|
|
| ePath Xeroderma pigmentosum Group A MIM 278700
|
|
| ePath Xeroderma pigmentosum Group B MIM 610651
|
|
| ePath Xeroderma pigmentosum Group C MIM 278720
|
|
| ePath Xeroderma pigmentosum Group D MIM 278730
|
|
| ePath Xeroderma pigmentosum Group E MIM 278740
|
|
| ePath Xeroderma pigmentosum Group F MIM 278760
|
|
| ePath Xeroderma pigmentosum Group G MIM 278780
|
|
| ePath Xeroderma pigmentosum variant MIM 278750
|
represents a damaged or inappropriate base, some examples of which are shown on the following line. These bases are cleaved of the backbone by the indicated glycosylases. Disorders resulting from enzymatic defects are indicated in parentheses below the enzyme.
